HIV prophylaxis
CD4 count determines need for ppx
<200 = bactrim or dapsone+ , or atovaqune (DC after cells 200+x3 months and remain on art; pjp ppx)
<100 = same as above (ppx toxoplasma)
<50 Azithro 1200 weekly (MAC ppx) d/c if takin fully supressive ART
Maraviroc moa
ccr5 antagonist (binding/attachment)
fostemsavir MOA
attachment inhibitor
ibalizumab uiyk moa
post-attachment inhibitor
NRTI/NNRTI MOA
reverse transcription
lenacapvir MOA
capsid inhibitor, prevent nuclear import
Assembly inhibito
budding/maturation
INSTI MOA
prevents integration (insertion of DNA into host cell)
Protease inhibitors
prevent budding and maturation
Pref initial ART
Biktarvy
Triumeq (5701)
Dovato (<500k)
Tivicay/Truvada (TDF)
Tivicay/Descovy (TAF)
Biktarvy
Bictegravir (INSTI)
Emtricitabine/TAF (NRTI x 2)
Triumeq
Dolutegravir (INSTI)
Abacavir/ Emtricitabine (NRTI x2)
Dovato
Dolutegravir (INSTI)
Emtricitabine (NRTI)
complete only if viral load <500k due to only 1 NRTI
Tivicay
Dolutegravir (INSTI)
Truvada
Emtricitabine/TAF (NRTI x 2 )
Descovy
Emtricitabine/TDF (NRTIx2)
Genvoya
Elvitegravir (INSTI)
Cobicistat (booster)
emtricitabine/TAF (NRTI x 2)
Striibild
same as genvoya but with TDF
Epzicom
abacavir (NRTI)
lamivudine (NRTI)
Cabenuva
cabotegravir (INSTI)
rilpiverine (NNRTI)
Rilpiverine
NEED ACID to absorb
Efavirenz
AVOID Food, too much absorb side effect CNS (QHS empty stomach)
Drugs with rilpiverine
cabenuva
juuluca
complera
odefsey
PREP
Truvada (3TC/TDF)
or
Descovy (3TC/TAF)
or
IM cabotegravir
Apretude
IM cabotegravir